Find your next paid study

Stanford UniversityNCT01034033

~$10 – $750

Actual pay is set by the research site.

Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies

This study is a single arm, non-randomized feasibility study with tolerability and toxicity evaluation as primary endpoints which seeks to determine if a modif…

GI Cancers

University of Vermont Medical CenterNCT06648785

~$75 – $2,000

Actual pay is set by the research site.

Head and Neck Cancers- Squamous CellHead and Neck CancerSolid Tumors+10 more

Study of Intratumoral Injections of VLPONC-01 in Head and Neck Cancer

The goal of this clinical trial is to assess the safety and tolerability of a virus replicon particle (VRP) encapsulated saRNA encoding IL-12 when injected int…

VLP TherapeuticsNCT06736379

~$150 – $4,200

Actual pay is set by the research site.

Locally Advanced or Metastatic HER2-Expressing Cancers

A Phase 1, Multicenter, Open-Label, First-in-Human Study of the Safety and Pharmacokinetics of VIR-5818 Alone and in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

This first-in-human (FIH) Phase 1 open-label multicenter dose-escalation and dose-expansion study is designed to evaluate the safety, pharmacokinetics, and pre…

Vir Biotechnology, Inc.NCT05356741

~$150 – $4,200

Actual pay is set by the research site.

Phase 3

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.

Lung Cancers

George Washington UniversityNCT06810375

~$50 – $1,500

Actual pay is set by the research site.

Pancreatobiliary CancersPancreatic Ductal Adenocarcinoma

A Phase 2, Open-Label, Master Protocol Study to Evaluate Safety and Efficacy of Treatment Combinations With Telisotuzumab Adizutecan in Subjects With Pancreatobiliary Cancers (AndroMETa-118)

Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The pancreas is a gland behind the stomach that produces a …

Rare CancersCholangiocarcinomaCancer of Unknown Primary Site

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT07769502

Observational

TCF-001 TRACK (Target Rare Cancer Knowledge) Study

This open label, non-randomized, multi-center, pragmatic study aims to establish whether patients with rare tumors can benefit from matched molecular therapy a…

TargetCancer FoundationNCT04504604

~$10 – $750

Actual pay is set by the research site.

Platinum Resistant Ovarian CancerFallopian Tube CancersPeritoneal Carcinoma

Phase I Study of Supplemental Arginine With Chemotherapy and Immunotherapy in Platinum Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer

This is an open-label, Phase 1 clinical study to evaluate the safety, tolerability, PK profiles, and clinical activity of IV and PO arginine supplementation + …

~$150 – $4,500

Actual pay is set by the research site.

Rebecca ArendNCT07772882

Prostate Cancer (Adenocarcinoma)Prostate CAProstate Cancers+4 more

A Multicenter, Adaptive, Phase 2, Randomized, Open-label Study of Irradiated Autologous Cellular Vaccine in Men With High-Risk Prostate Cancer Following Prostatectomy

The goal of this clinical trial is to learn if the vaccine FK-PC101 works to delay or prevent the return of prostate cancer in men who have had surgery to remo…

Cellvax Therapeutics IncNCT06636682

~$75 – $2,800

Actual pay is set by the research site.

Cutaneous Squamous Cell CarcinomaSkin Cancers - Squamous Cell Carcinoma

Phase Ib/II Study of Micro-needle Array Containing Doxorubicin in Immune Competent or Immune-suppressed Patients With Cutaneous Squamous Cell Carcinoma

The purpose of this study is to test a new method of experimental treatment for cutaneous squamous cell skin cancer, using small adhesive-like patches (a micro…

Falo, Louis, MDNCT05377905

~$150 – $4,500

Actual pay is set by the research site.

GlandSalivary Gland Cancers

Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers

To learn if sacituzumab govitecan can help to control salivary gland cancer.

M.D. Anderson Cancer CenterNCT05884320

~$75 – $2,000

Actual pay is set by the research site.

Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies

Background: * Chromatin is is the structural building block of a chromosome. It is found inside the nucleus of the cell and consists of a complex of DNA and p…

Thoracic CancersMalignant Pleural Mesotheliomas NOSLung Cancer NOS+3 more